Addressing the management of atrial fibrillation &ndash; a systematic review of the role of dronedarone

Addressing the management of atrial fibrillation &ndash; a systematic review of the role of dronedarone

Gian Marco Podda,1 Giovanni Casazza,2 Francesco Casella,3 Franca Dipaola,4 Emanuela Scannella,3 Ludovica Tagliabue51Medicina III, Department of Medicine, Surgery and Dentistry, San Paolo Hospital, University of Milan, Milan, Italy; 2Department of Clinical Science, &quot;L. Sacco&quot...

Full description

Bibliographic Details
Main Authors:	Podda GM, Casazza G, Casella F, Dipaola F, Scannella E, Tagliabue L
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-05-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/addressing-the-management-of-atrial-fibrillation-ndash-a-systematic-re-a9976

Similar Items

Cost considerations in the management of atrial fibrillation &ndash; impact of dronedarone
by: Khaykin Y, et al.
Published: (2012-03-01)

Dronedarone for the management of atrial fibrillation
by: Swiss Medical Weekly
Published: (2011-02-01)

Dronedarone in the management of atrial fibrillation
by: TS Mohamed Saleem, et al.
Published: (2010-03-01)

Dronedarone for the treatment of atrial fibrillation and atrial flutter
by: E Maund, et al.
Published: (2010-10-01)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
by: Deborah Wolbrette, et al.
Published: (2010-06-01)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
by: Gerald V. Naccarelli, et al.
Published: (2011-10-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
by: Trigo P, et al.
Published: (2011-12-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
by: Christine Benn Christiansen, et al.
Published: (2010-03-01)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
by: Gerald V. Naccarelli, et al.
Published: (2011-01-01)

Dronedarone for atrial fibrillation: a new therapeutic agent
by: Pawan D Patel, et al.
Published: (2009-08-01)

Elevated liver enzymes associated with dronedarone for atrial fibrillation
by: Kelly R Ragucci
Published: (2013-11-01)

Observational study of dronedarone in Taiwanese patients with atrial fibrillation
by: Jiunn-Lee Lin, et al.
Published: (2020-01-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
by: M. Yu. Gilyarov, et al.
Published: (2010-12-01)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
by: Jordi Heijman, et al.
Published: (2013-08-01)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
by: Jordi Heijman, et al.
Published: (2013-01-01)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
by: Patrick A Schweizer, et al.
Published: (2011-01-01)

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone
by: Chahal CAA, et al.
Published: (2012-12-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021-08-01)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
by: John Marcus Wharton, et al.
Published: (2022-02-01)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Published: (2023-10-01)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Published: (2022-05-01)

Preventing stroke in atrial fibrillation patients &ndash; clinical utility of oral anticoagulants
by: Jhawar MB, et al.
Published: (2012-04-01)

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
by: Li Y, et al.
Published: (2023-12-01)

Dronedarone-induced photoallergic reaction
by: Levy Amar, PhD, et al.
Published: (2020-12-01)

Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
by: Adam Corey, et al.
Published: (2016-12-01)

Dronedarone for Recurrent Ventricular Tachycardia: A Real Alternative?
by: Victor Exposito, MD, et al.
Published: (2012-03-01)

Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
by: Li-Qin Jiang, et al.
Published: (2016-05-01)

Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004–2018
by: Hegelund ER, et al.
Published: (2022-10-01)

Bioavailability of dronedarone tablets administered with or without food in healthy participants
by: Gerald V. Naccarelli, et al.
Published: (2024-09-01)

Marked prolongation of QRS duration after initiation of dronedarone therapy
by: Conrad Genz, et al.
Published: (2014-08-01)

Plaque psoriasis in children and adolescents &ndash; the role of etanercept
by: Ricceri F, et al.
Published: (2012-06-01)

The Role of Atrial Remodelling in Atrial Fibrillation
by: Ignatius Yansen, et al.
Published: (2013-06-01)

Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study
by: Po-Lin Lin MD, et al.
Published: (2021-12-01)

Sleep paralysis in medieval Persia &ndash; the Hidayat of Akhawayni (? &ndash;983 AD)
by: Golzari SE, et al.
Published: (2012-06-01)

Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone
by: Yuyan Chen, PM, et al.
Published: (2024-01-01)

Dronedarone produces early regression of myocardial remodelling in structural heart disease.
by: Begoña Quintana-Villamandos, et al.
Published: (2017-01-01)

Nanocalcium-deficient hydroxyapatite&ndash;poly (&epsilon;-caprolactone)&ndash;polyethylene glycol&ndash;poly (&epsilon;-caprolactone) composite scaffolds
by: Wang Z, et al.
Published: (2012-07-01)

Atrial AMP-activated protein kinase is critical for prevention of dysregulation of electrical excitability and atrial fibrillation
by: Kevin N. Su, et al.
Published: (2022-05-01)

Role of the left atrial appendage “stump” in persistent atrial fibrillation
by: Jorge Romero, MD, et al.
Published: (2018-02-01)

Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC
by: Xuebo Lu, et al.
Published: (2024-12-01)